Related Experiment Video

Updated: Aug 19, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.3K

Tools for communicating risk for Parkinson's disease

Lola Cook1, Jeanine Schulze2, Wendy R Uhlmann3

  • 1Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA. lpcook@iu.edu.

NPJ Parkinson'S Disease
|November 29, 2022
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

25.7K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.9K

Related Experiment Videos

Last Updated: Aug 19, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.3K
Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

25.7K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.9K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

660
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
660
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

345
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
345

Articles linked to this work by shared authors, journal, and citation graph.

CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.

Nature communications·2026

Common and rare variant analyses implicate JARID2 in cerebral tau deposition.

NPJ dementia·2026

Combining post-mortem and neuroimaging measures of brain amyloidosis to accelerate genomic discovery.

Brain : a journal of neurology·2026

PD GENEration: An International Parkinson's Disease Genetic Research Study.

medRxiv : the preprint server for health sciences·2026

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Movement disorders : official journal of the Movement Disorder Society·2026

Return of results is important to heterogeneous research participants: A single-site survey.

Journal of clinical and translational science·2026

Pesticide exposure and multidomain symptom burden in Parkinson's disease: a longitudinal triangulation study.

NPJ Parkinson's disease·2026

Dopamine-related alterations in functional brain network dynamic reconfiguration in Parkinson's disease.

NPJ Parkinson's disease·2026

APCDD1 shows high specificity for ventral midbrain dopaminergic progenitors in a cell surface marker benchmarking study.

NPJ Parkinson's disease·2026

Plasma ceramide ratios define metabolic-inflammatory associations with cognitive impairment in Parkinson's disease.

NPJ Parkinson's disease·2026

STN-DBS and LCIG differentially affect long-term axial symptoms in Parkinson's disease.

NPJ Parkinson's disease·2026

fMRI during active GPi DBS uncovers target-specific networks.

NPJ Parkinson's disease·2026

Dual-Layered, pH-Responsive PLGA-Based Nanocarriers for Enhanced Niclosamide Delivery and Anticancer Activity.

ACS applied bio materials·2026

Pathogen-phage geomapping to overcome resistance.

eLife·2026

Challenges in Designing Clinical Trials to Test New Drugs in the Pregnant and Breastfeeding Woman.

Clinics in perinatology·2026

A novel scaling approach for human pharmacokinetic prediction of antibody-drug conjugates using minimal nonclinical data: Integration of monkey PK and in vitro data.

Drug metabolism and pharmacokinetics·2026

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Analysis by Age and Sex.

Journal of drugs in dermatology : JDD·2026

BetaH proteolysis unleashes an electrostatic-homing antibacterial polymorphic toxin.

mBio·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us